Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8K4Q0
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8K4Q0-F1 | Predicted | AlphaFoldDB |
No variants for Q8K4Q0
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q8K4Q0 | |||||
No associated diseases with Q8K4Q0
Functions
8 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytoplasmic stress granule | A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| lysosome | A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
| neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| TORC1 complex | A protein complex that contains at least TOR (target of rapamycin) and Raptor (regulatory-associated protein of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of S6K. In Saccharomyces, the complex contains Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p. |
10 GO annotations of molecular function
| Name | Definition |
|---|---|
| 14-3-3 protein binding | Binding to a 14-3-3 protein. A 14-3-3 protein is any of a large family of approximately 30kDa acidic proteins which exist primarily as homo- and heterodimers within all eukaryotic cells, and have been implicated in the modulation of distinct biological processes by binding to specific phosphorylated sites on diverse target proteins, thereby forcing conformational changes or influencing interactions between their targets and other molecules. Each 14-3-3 protein sequence can be roughly divided into three sections: a divergent amino terminus, the conserved core region and a divergent carboxy-terminus. The conserved middle core region of the 14-3-3s encodes an amphipathic groove that forms the main functional domain, a cradle for interacting with client proteins. |
| protein kinase activator activity | Binds to and increases the activity of a protein kinase, an enzyme which phosphorylates a protein. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| protein serine/threonine kinase inhibitor activity | Binds to and stops, prevents or reduces the activity of a protein serine/threonine kinase. |
| protein-containing complex binding | Binding to a macromolecular complex. |
| protein-macromolecule adaptor activity | The binding activity of a protein that brings together two or more macromolecules in contact, permitting those molecules to function in a coordinated way. The adaptor can bring together two proteins, or a protein and another macromolecule such as a lipid or a nucleic acid. |
| RNA polymerase III type 1 promoter sequence-specific DNA binding | Binding to a sequence of DNA that is a part of a type 1 promoter that controls transcription by RNA polymerase III. Type 1 promoters are found in 5S rRNA genes, downstream of the transcription start site within the sequence of the mature RNA, and require TFIIIA for recognition. |
| RNA polymerase III type 2 promoter sequence-specific DNA binding | Binding to a sequence of DNA that is a part of a type 2 promoter that controls transcription by RNA polymerase III. Type 2 promoters consist of an A box and a B box downstream of the transcription start site within the sequence within the sequence of the mature RNA. Type 2 promoters are found in many tRNA genes as well as in other small RNAs. |
| RNA polymerase III type 3 promoter sequence-specific DNA binding | Binding to a sequence of DNA that is a part of a type 3 promoter that controls transcription by RNA polymerase III (Pol III). A type 3 Pol III promoter is composed of elements upstream of the transcription start site, including a TATA box. The human U6 snRNA gene has a type 3 promoter. Type 3 Pol III promoters have not been observed in S. cerevisiae. |
| TFIIIC-class transcription factor complex binding | Binding to a general RNA polymerase III transcription factor belonging to the TFIIC complex, one of the factors involved in formation of the preinitiation complex (PIC) by RNA polymerase III. |
30 GO annotations of biological process
| Name | Definition |
|---|---|
| cellular response to amino acid stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
| cellular response to DNA damage stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
| cellular response to hypoxia | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| cellular response to leucine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leucine stimulus. |
| cellular response to nutrient levels | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
| cellular response to osmotic stress | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell. |
| cellular response to starvation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment. |
| negative regulation of autophagy | Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
| negative regulation of insulin secretion | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin. |
| phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
| positive regulation of cell growth | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
| positive regulation of endothelial cell proliferation | Any process that activates or increases the rate or extent of endothelial cell proliferation. |
| positive regulation of G1/S transition of mitotic cell cycle | Any signalling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle. |
| positive regulation of glycolytic process | Any process that activates or increases the frequency, rate or extent of glycolysis. |
| positive regulation of lipid biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids. |
| positive regulation of pentose-phosphate shunt | Any process that activates or increases the frequency, rate or extent of pentose-phosphate shunt. |
| positive regulation of peptidyl-serine phosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| positive regulation of peptidyl-threonine phosphorylation | Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
| positive regulation of protein serine/threonine kinase activity | Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity. |
| positive regulation of TOR signaling | Any process that activates or increases the frequency, rate or extent of TOR signaling. |
| positive regulation of transcription by RNA polymerase III | Any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase III. |
| regulation of autophagy | Any process that modulates the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
| regulation of cell growth | Any process that modulates the frequency, rate, extent or direction of cell growth. |
| regulation of cell size | Any process that modulates the size of a cell. |
| regulation of phosphorylation | Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule. |
| regulation of protein phosphorylation | Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein. |
| response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
| social behavior | Behavior directed towards society, or taking place between members of the same species. Occurs predominantly, or only, in individuals that are part of a group. |
| TOR signaling | The series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors. |
| TORC1 signaling | A series of intracellular molecular signals mediated by TORC1; TOR (target of rapamycin) in complex with at least Raptor (regulatory-associated protein of TOR), or orthologs of, and other signaling components. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MESEMLQSPL | MGLGEEDEAD | LTDWNLPLAF | MKKRHCEKIE | GSKSLAQSWR | MKDRMKTVSV |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ALVLCLNVGV | DPPDVVKTTP | CARLECWIDP | LSMGPQKALE | TIGANLQKQY | ENWQPRARYK |
| 130 | 140 | 150 | 160 | 170 | 180 |
| QSLDPTVDEV | KKLCTSLRRN | AKEERVLFHY | NGHGVPRPTV | NGEVWVFNKN | YTQYIPLSIY |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DLQTWMGSPS | IFVYDCSNAG | LIVKSFKQFA | LQREQELEVA | AINPNHPLAQ | MPLPPSMKNC |
| 250 | 260 | 270 | 280 | 290 | 300 |
| IQLAACEAHE | LLPMIPDLPA | DLFTSCLTTP | IKIALRWFCM | QKCVSLVPGV | TLDLIEKIPG |
| 310 | 320 | 330 | 340 | 350 | 360 |
| RLNDRRTPLG | ELNWIFTAIT | DTIAWNVLPR | DLFQKLFRQD | LLVASLFRNF | LLAERIMRSY |
| 370 | 380 | 390 | 400 | 410 | 420 |
| NCTPVSSPRL | PPTYMHAMWQ | AWDLAVDICL | SQLPTIIEEG | TAFRHSPFFA | EQLTAFQVWL |
| 430 | 440 | 450 | 460 | 470 | 480 |
| TMGVENRSPP | EQLPIVLQVL | LSQVHRLRAL | DLLGRFLDLG | PWAVSLALSV | GIFPYVLKLL |
| 490 | 500 | 510 | 520 | 530 | 540 |
| QSSARELRPL | LVFIWAKILA | VDSSCQADLV | KDNGHKYFLS | VLADPYMPAE | HRTMTAFILA |
| 550 | 560 | 570 | 580 | 590 | 600 |
| VIVNSYTTGQ | EACLQGNLIA | ICLEQLSDPH | PLLRQWVAIC | LGRIWQNFDS | ARWCGVRDSA |
| 610 | 620 | 630 | 640 | 650 | 660 |
| HEKLYSLLSD | PIPEVRCAAV | FALGTFVGNS | AERTDHSTTI | DHNVAMMLAQ | LINDGSPMVR |
| 670 | 680 | 690 | 700 | 710 | 720 |
| KELVVALSHL | VVQYESNFCT | VALQFMEEEK | NYPLPSPAAT | EGGSLTPVRD | SPCTPRLRSV |
| 730 | 740 | 750 | 760 | 770 | 780 |
| SSYGNIRAVT | TARNLNKSLQ | NLSLTEESGS | SVAFSPGNLS | TSSSASSTLG | SPENEEYILS |
| 790 | 800 | 810 | 820 | 830 | 840 |
| FETIDKMRRV | SSYSALNSLI | GVSFNSVYTQ | IWRVLLHLAA | DPYPDVSDLA | MKVLNSIAYK |
| 850 | 860 | 870 | 880 | 890 | 900 |
| ATVNARPQRI | LDTSSLTQSA | PASPTNKGMH | MHQVGGSPPA | SSTSSCSLTN | DVAKQTVSRD |
| 910 | 920 | 930 | 940 | 950 | 960 |
| LPSSRPGTAG | PTGAQYTPHS | HQFPRTRKMF | DKGPDQTTDD | ADDAAGHKSF | ICASMQTGFC |
| 970 | 980 | 990 | 1000 | 1010 | 1020 |
| DWSARYFAQA | VMKIPEEHDL | ESQIRKEREW | RFLRNTRVRK | QAQQVIQKGI | TRLDDQIFLN |
| 1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
| RNPGVPSVVK | FHPFTPCIAV | ADKDSICFWD | WEKGEKLDYF | HNGNPRYTRV | TAMEYLNGQD |
| 1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
| CSLLLTATDD | GAIRVWKNFA | DLEKNPEMVT | AWQGLSDMLP | TTRGAGMVVD | WEQETGLLMS |
| 1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
| SGDVRIVRIW | DTDRETKVQD | IPTGADSCVT | SLSCDSHRSL | IVAGLGDGSI | RVYDRRMALS |
| 1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
| ECRVMTYREH | TAWVVKAYLQ | KHPEGHIVSV | SVNGDVRFFD | PRMPESVNVM | QIVKGLTALD |
| 1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
| IHPQANLIAC | GSMNQFTAIY | NGNGELINNI | KYYDGFMGQR | VGAISCLAFH | PHWPHLAVGS |
| 1330 | |||||
| NDYYISVYSV | EKRVR |